BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//APPG for Prescribed Drug Dependence - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:APPG for Prescribed Drug Dependence
X-ORIGINAL-URL:https://prescribeddrug.org
X-WR-CALDESC:Events for APPG for Prescribed Drug Dependence
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Helsinki
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20191112T090000
DTEND;TZID=Europe/Helsinki:20191112T110000
DTSTAMP:20260418T161219
CREATED:20190912T133240Z
LAST-MODIFIED:20191211T113247Z
UID:10491-1573549200-1573556400@prescribeddrug.org
SUMMARY:EU Policy Dialogue on Employment and Chronic Conditions
DESCRIPTION:Click here to read the rationale and aims of this policy dialogue\nDownload the introductory presentation of the event\nAGENDA\nWelcome\nMassimiliano Salini\, MEP\n[embedyt] https://www.youtube.com/watch?v=5CE6gJ22eHU[/embedyt]\n\n\n\n\nChrodis Plus Joint Action \nRokas Navickas\, VULSK Lithuania\, Chrodis Plus Scientific Coordinator\n[embedyt] https://www.youtube.com/watch?v=RGY9ayxxc40[/embedyt]\n\n  \nEmployment and Chronic Conditions: a European Challenge\nThe Chrodis Plus Toolbox\nMatilde Leonardi\, FINCB Italy\, Chrodis Plus WP8 Leader\nJaana Lindstrom\, Eeva Rantala\, THL Finland\, Chrodis Plus WP8 Co-leader\n[embedyt] https://www.youtube.com/watch?v=xY3q1A0opX4[/embedyt]\n\n\n\n\n\nRound table\nAddressing the impact of chronic diseases in the employment sector.\nWhat are the practical steps for EU policy to support employment for people with chronic diseases?\nModerator: Clive Needle\, EuroHealthNet\, Brussels\nKatie Gallager\, European Patients Forum\, EPF\nRaymond Vanholder\, European Chronic Disease Alliance\, ECDA\nAlberto Lapi\, Accenture\, Representative of Enterprises\nSarah Cospey\, European Agency for Safety and Health at Work\, EU-OSHA\nAnna Ludwinek\, European Foundation for Improvement of Living &Working Conditions EUROFOUND\nMartin Jefflen\, Trade Union voice of professionals and managers\, EUROCADRES \n  \n\n\n\nWhy best practices delivered by Chrodis Plus are significant?\nClive Needle | EuroHealthNet\n\n[embedyt] https://www.youtube.com/watch?v=u28xyxv1t_0[/embedyt]\n\n\n\n\n\n\nExplaining the practical use and benefits of the Chrodis Plus Toolbox\nKatie Gallagher | European Patients Forum\n\n[embedyt] https://www.youtube.com/watch?v=SyqxWK9x5Rk[/embedyt]\n\n\n\n\n\n\nSummary\nThe increasing prevalence of chronic conditions in Europe’s working age population underlines the need for a European strategy towards inclusion\, integration and reintegration of employees in the workplace as well as towards the development of actions to support workers’ health and wellbeing. \nThe JA Chrodis Plus Policy Dialogue on employment and chronic conditions will aim to identify the practical steps for EU policy to support employment for people with chronic diseases and to address the impact of chronic diseases in the employment sector. \nEpidemiological transition and ageing across Europe is resulting in a rise of chronic diseases in the working population that will impact on the health and welfare sectors as well as an employment sector. This is a crucial issue for European and national policy makers\, patients\, NGOs\, academies\, and civil society which need legal\, social\, political and technical tools to face the challenge. Relevant stakeholders need to be encouraged to implement actions on the employment and chronic conditions at European and national level. The European Union has a significant role to play in supporting and encouraging national labour reforms\, sharing innovative ideas and helping to create successful policy frameworks. \nQuestions for the Round Table discussion \n\nWhat are the practical steps for EU policy to support employment for people with chronic diseases and to address the impact of chronic diseases in the employment sector?\nHow can the EU support health promotion and disease prevention in the workplace for people with or at risk for chronic conditions?\nCan policies and implementation of best practices tackle the employment sector as an area where care of people’s health should be improved?\nHow can EU Policy support the implementation of the TOOLBOX: Training Tool and Toolkit?\nHow can the Chrodis Plus Training Tool and Toolkit promote or support existing European policies on inclusion and work ability of people with chronic conditions?\n\n\n\nAims of the EU Policy Dialogue on Employment and Chronic Conditions: \n\n\n\nbring together EU stakeholders for a common understanding of the benefits of the workplace inclusion\, integration and reintegration of people with chronic conditions\,\npresent the Chrodis Plus Toolbox on Employment and Chronic Conditions developed within the EU Joint Action CHRODIS PLUS. This Toolbox includes a Training Tool for managers on workplace inclusion and work ability and a Toolkit for workplace adaptation\, health promotion and disease prevention. The TOOLBOX  will be freely available in different languages on the Chrodis website from April 2020.\n\nExpected outcomes:\n\nto draw attention to the effect that chronic conditions have in the work sector by adopting interventions and strategies that approach health in all sectors\,\nto encourage all relevant stakeholders to implement the Chrodis Plus Toolbox\n\n\nCHRODIS PLUS Work Package 8 on Employment and Chronic Conditions (https://prescribeddrug.org/08-employment/) involves 12 institutional partners from 10 different European countries and aims to: \n\nImplement good practices in the employment sector for people with chronic conditions: development of CHRODIS-PLUS Training tool for managers\nDevelop a CHRODIS-PLUS Toolkit for adaptation of the workplace for access\, prevention and maintenance of chronic conditions at the workplace\nDevelop a road map for health promotion and disease prevention (HPDP) in the workplace for people with chronic conditions including access to\, reintegration\, maintenance and stay at work tackling the employment sector as an area where care of people with chronic conditions should be improved\, by policies and implementation of best practices.\n\nOfficial language: English \nPicture gallery of the event \n[Best_Wordpress_Gallery id=”85″ gal_title=”WP8 EU Policy Dialogue”]
URL:https://prescribeddrug.org/event/eu-policy-dialogue-on-employment-and-chronic-conditions/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20191112T130000
DTEND;TZID=Europe/Helsinki:20191114T140000
DTSTAMP:20260418T161219
CREATED:20190807T121858Z
LAST-MODIFIED:20190912T132032Z
UID:10446-1573563600-1573740000@prescribeddrug.org
SUMMARY:European Patients' Forum Congress
DESCRIPTION:Congress programme\nCongress registration\nWe are happy to announce that on 12-14 November 2019 the European Patients’ Forum will hold the first ever European Congress on patient involvement. \nThis event will be driven by leading representatives of the patient community\, and patient experts\, in the capital of the European Union. \nThe event will also provide an exceptional opportunity for dialogue\, engagement with a wide range of health players who aspire to make patient involvement a reality. \nThis Congress is aimed at exchanging ideas and good practices in patient empowerment and involvement\, moving forward on the much-needed policy commitments in this area\, gaining a greater and genuine understanding of the wealth of expertise that patients bring to health systems’ design and strengthening\, and much more! \nStay tuned for programme details\, speakers updates and other highlights by subscribing to the Congress newsletter\, and take a look at the latest version of the programme here. \n 
URL:https://prescribeddrug.org/event/european-patients-forum-congress/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20200218T090000
DTEND;TZID=Europe/Helsinki:20200218T123000
DTSTAMP:20260418T161219
CREATED:20200220T084549Z
LAST-MODIFIED:20200220T084549Z
UID:10745-1582016400-1582029000@prescribeddrug.org
SUMMARY:Chrodis Plus Policy Dialogue in Hungary
DESCRIPTION:The Chrodis Plus policy dialogue held in Budapest\, Hungary on 18 February 2020 has addressed the role of AI and BI solutions in medical decision support solutions. \nNational screening programs are potentially the most profitable public services in the health system\, with the highest per-unit cost. There is a strong social interest in the efficient running of programs\, so it is vital to incorporate state-of-the-art IT solutions as widely as possible. During the dialogue\, participants looked at two options for information technology: \n\n Technology assessment and regulatory environment\n Artificial intelligence and deep learning algorithms\n\nArtificial intelligence solutions can play a primary role in evaluating the results\, supporting medical decision-making and improving the effectiveness of screening programs. Numerous publications are available that corroborate the diagnostic effectiveness of deep learning algorithms\, primarily in medical imaging\,  but also in other medical decision areas. During the dialogue\, we assessed which programs could be assisted by AI\, what the prerequisites are\, how we can create a training database that supports algorithm development\, and how we can build an IT infrastructure capable of serving a national program. \nThe medical application of artificial intelligence also raises new regulatory issues. There are many situations in which artificial intelligence decides whether a person’s condition requires medical attention. For example\, remote monitoring of patients with chronic illnesses\, where processing large amounts of data without computer support is unthinkable. Regulating the application of AI technology and clarifying liability issues give legislators tasks. AI also poses new challenges in technology assessment procedures. AI as a decision making support for medical staff can contribute to the detection of chronic diseases at an early stage\, thus alleviate national healthcare systems from the burden of treating acute chronic diseases. AI is based on extracting knowledge from massive pools of data\, which demands the creation of data pools at national or international level. This needs government interaction at three levels:  \n– IT infrastructure: sound IT systems collecting\, storing and distributing data \n– Process management: well designed patient pathways that allow an optimal access of patient to screening supported by AI \n– Legal regulations: a transparent legal background including data protection regulations\, a transparent distribution of access rights to data \n  \nDetailed report about the event will be added to this page by 18 March 2020. \n 
URL:https://prescribeddrug.org/event/chrodis-plus-policy-dialogue-in-hungary/
LOCATION:Budapest\, Budapest\, Hungary
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20201002T113000
DTEND;TZID=Europe/Helsinki:20201002T130000
DTSTAMP:20260418T161219
CREATED:20200819T111755Z
LAST-MODIFIED:20200819T122632Z
UID:11361-1601638200-1601643600@prescribeddrug.org
SUMMARY:Closing the evidence-practice gap on NCDs: Translation\, transfer and sustainability for comprehensive responses across Europe
DESCRIPTION:The session is part of the online conference ‘EHFG 2020: Dancing with elephants: New partnerships for health\, democracy\, business’ organized by the European Health Forum Gastein. \n \nOn the surface\, the steps to closing the gap between research findings and existing clinical practice are simple: 1. Identifying good practice; 2. Piloting; 3. Scaling-up. However\, promising initiatives – and the big players overseeing them – often get stuck at the first step. At the same time\, mechanisms like crowdfunding and startups have proven to mark a shift from the few major players towards community driven initiatives\, often based on ideas and passion. \nThis session will showcase how ideas and passion on a small scale can be transferred to cross-national learning while respecting national interests\, and explore the success factors to piloting\, transferring and sustaining good practices that benefit patients affected by chronic disease. We will showcase outcomes of the CHRODIS+ Joint Action\, focused on supporting Member States in scaling up practices aimed at reducing the burden of non-communicable diseases\, and discuss how learnings on both the successes and barriers from the Joint Action can be taken forward to help health stakeholders achieve policy impact in the future. Join us to be guided through the potential dancing steps of ambitious partnerships in the battle against chronic disease!
URL:https://prescribeddrug.org/event/closing-the-evidence-practice-gap-on-ncds-translation-transfer-and-sustainability-for-comprehensive-responses-across-europe/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Helsinki:20201027T093000
DTEND;TZID=Europe/Helsinki:20201027T170000
DTSTAMP:20260418T161219
CREATED:20200717T100411Z
LAST-MODIFIED:20240519T122030Z
UID:11106-1603791000-1603818000@prescribeddrug.org
SUMMARY:Chrodis Plus Online Conference on Chronic Diseases
DESCRIPTION:ON BEHALF OF JOINT ACTION CHRODIS PLUS\n WE WOULD LIKE TO THANK YOU FOR YOUR PARTICIPATION AT THE CONFERENCE\nKey conference materials will be made available soon here. \n[table id=30 /]\nPRESS RELEASE\nOver its 3-year lifespan\, the aim of CHRODIS PLUS Joint Action (2017-2020) was to support Member States in overcoming the burden of chronic diseases by promoting policies and practices that have proved successful in the past. Further refinement and EU cross-border sharing of these tested policies and good practices has been the core idea behind this pan-European project. \nCHRODIS PLUS has implemented 21 pilot projects aimed at testing tools and good practices for certain chronic diseases\, and held 17 policy dialogues (15 national and 2 EU-level ones). It has brought together over 50 partners from 21 European countries. \nAll good things come to an end: CHRODIS PLUS held its closing online conference on 27 October 2020. \nThis conference illustrated the impact that CHRODIS PLUS has had on public health systems across EU member states over the past 3 years. It focused on showing how the good practices\, models and tools implemented by the project can be tailored to various national and local settings across Europe. \nThe conference’s presentations and roundtable discussions were structured around the project’s key focus areas: \n\nHealth Promotion & Primary Prevention\nAn Integrated Multimorbidity Care Model\nFostering Quality Care for People with Chronic Diseases\nICT-based Patient Empowerment\nEmployment & Chronic Diseases
URL:https://prescribeddrug.org/event/chrodis-plus-online-conference-on-chronic-diseases/
END:VEVENT
END:VCALENDAR